Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes. 2023

Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
Department of Laboratory, Ninth Forty Hospital of the Chinese People's Liberation Army Joint Security Force, Lanzhou 730050, Gansu, China; School of Public Health, Gansu University of Traditional Chinese Medicine, Lanzhou 730000, Gansu, China.

Protein kinase C (PKC) is a family of serine/threonine protein kinases that play an important role in many organs and systems and whose activation contributes significantly to endothelial dysfunction in diabetes. The increase in diacylglycerol (DAG) under high glucose conditions mediates PKC activation and synthesis, which stimulates oxidative stress and inflammation, resulting in impaired endothelial cell function. This article reviews the contribution of PKC to the development of diabetes-related endothelial dysfunction and summarizes the drugs that inhibit PKC activation, with the aim of exploring therapeutic modalities that may alleviate endothelial dysfunction in diabetic patients.

UI MeSH Term Description Entries
D011493 Protein Kinase C An serine-threonine protein kinase that requires the presence of physiological concentrations of CALCIUM and membrane PHOSPHOLIPIDS. The additional presence of DIACYLGLYCEROLS markedly increases its sensitivity to both calcium and phospholipids. The sensitivity of the enzyme can also be increased by PHORBOL ESTERS and it is believed that protein kinase C is the receptor protein of tumor-promoting phorbol esters. Calcium Phospholipid-Dependent Protein Kinase,Calcium-Activated Phospholipid-Dependent Kinase,PKC Serine-Threonine Kinase,Phospholipid-Sensitive Calcium-Dependent Protein Kinase,Protein Kinase M,Calcium Activated Phospholipid Dependent Kinase,Calcium Phospholipid Dependent Protein Kinase,PKC Serine Threonine Kinase,Phospholipid Sensitive Calcium Dependent Protein Kinase,Phospholipid-Dependent Kinase, Calcium-Activated,Serine-Threonine Kinase, PKC
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014652 Vascular Diseases Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body. Disease, Vascular,Diseases, Vascular,Vascular Disease
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D018384 Oxidative Stress A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi). Anti-oxidative Stress,Antioxidative Stress,DNA Oxidative Damage,Nitro-Oxidative Stress,Oxidative Cleavage,Oxidative DNA Damage,Oxidative Damage,Oxidative Injury,Oxidative Nitrative Stress,Oxidative Stress Injury,Oxidative and Nitrosative Stress,Stress, Oxidative,Anti oxidative Stress,Anti-oxidative Stresses,Antioxidative Stresses,Cleavage, Oxidative,DNA Damage, Oxidative,DNA Oxidative Damages,Damage, DNA Oxidative,Damage, Oxidative,Damage, Oxidative DNA,Injury, Oxidative,Injury, Oxidative Stress,Nitrative Stress, Oxidative,Nitro Oxidative Stress,Nitro-Oxidative Stresses,Oxidative Cleavages,Oxidative DNA Damages,Oxidative Damage, DNA,Oxidative Damages,Oxidative Injuries,Oxidative Nitrative Stresses,Oxidative Stress Injuries,Oxidative Stresses,Stress Injury, Oxidative,Stress, Anti-oxidative,Stress, Antioxidative,Stress, Nitro-Oxidative,Stress, Oxidative Nitrative,Stresses, Nitro-Oxidative

Related Publications

Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
June 2017, International journal of molecular sciences,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
May 2006, Cardiovascular research,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
January 2005, Cardiology in review,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
September 2006, Clinical cancer research : an official journal of the American Association for Cancer Research,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
August 2019, Journal of cellular physiology,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
May 2009, Cardiovascular research,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
December 2021, Biomedicines,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
December 2012, Nature reviews. Drug discovery,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
August 2002, Expert opinion on therapeutic targets,
Qian Xiao, and Dan Wang, and Danyang Li, and Jing Huang, and Feifei Ma, and Haocheng Zhang, and Yingda Sheng, and Caimei Zhang, and Xiaoqin Ha
May 2021, Signal transduction and targeted therapy,
Copied contents to your clipboard!